Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

NCT02821507 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Conventional Chondrosarcoma
Myxoid Liposarcoma
Mesenchymal Chondrosarcoma
Dedifferentiated Chondrosarcoma

Interventions

DRUG: sirolimus and cyclophosphamide

Sponsor

Leiden University Medical Center